Luminex Corporation Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Luminex Corp. (LMNX) Tops Q1 EPS by 4c, Revenues Beat; FY20 Outlook: 'Confident We Will Beat Top End of Current Revenue Guidance'
May 4, 2020 4:46 PM EDTLuminex Corp. (NASDAQ: LMNX) reported Q1 EPS of $0.01, $0.04 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $90.42 million versus the consensus estimate of $84.07 million.
CURRENT HIGHLIGHTS
Total revenue for the first quarter of $90.4M, a 10% increase over Q1 2019Molecular Diagnostic revenue for the quarter of $45.2M, up 28% over Q1 2019Sample-to-answer MDx revenue of $26.3M, up 38% over Q1 2019Non-Automated MDx revenue of $18.9M, up 17% over Q1 2019Life Science and Clinical Tools revenue for the quarter of $43.3M, down 6% vs. Q1 2019Licensed... More